Zhongzhi Pharmaceutical Holdings (HKSE:03737) Growth Rank : 5 (As of Apr. 28, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Growth Rank?

Zhongzhi Pharmaceutical Holdings has the Growth Rank of 5.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongzhi Pharmaceutical Holdings's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Growth Rank falls into.

Save Embed

;

Save Embed

;

Zhongzhi Pharmaceutical Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Growth Rank

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines